The neurologist at the UCSF Edward and Pearl Fein Memory and Aging Center discusses how the first platform trial in progressive supranuclear palsy could accelerate the evaluation of potential disease-modifying therapies. [WATCH TIME: 4 minutes]
Julio Rojas, MD, PhD
Advertisement
Articles by Julio Rojas, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Charting the Next Wave of Advancements in Movement Disorders Care
2
First Report of MOG-IgG in Breast Milk After Severe MOGAD
3
Remibrutinib Meets Primary End Point in Phase 3 REMODEL Trials for Relapsing Multiple Sclerosis
4
Combined Risk Factors Associated With Greater Risk of Late-Onset Parkinson Disease
5